Oncopeptides is a Swedish biopharmaceutical company that develops peptide-based medicines for the treatment of cancer. Its work centres on peptide-drug conjugate technology, which links a cancer drug to a peptide that helps it enter tumour cells. The company's main candidate is used in research on multiple myeloma, a cancer of the blood. Oncopeptides is based in Stockholm, Sweden, and carries out drug development and related activities aimed at oncology treatment.
The shares are listed on the Stockholm Exchange in Sweden under the code ONCO, and the price on this page is in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #568 of 911 on the Stockholm Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Sweden yet.
TrendWeak
37/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-9.7%
From 52-week high-69.5%
MomentumFair
58/100
Typical recent returns for this exchange.
See the numbers →
3-month return6.0%
6-month return28.6%
12-month, skipping last month-57.6%
Stability (higher is calmer)Weak
13/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)102.7%
Worst drawdown, 1 year (smaller is calmer)-77.7%
LiquidityStrong
80/100
Trades actively.
See the numbers →
Avg daily value traded10.99M SEK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Sweden when fundamentals data for this market is added. All Sweden stocks.
52-wk range 1.255 – 5.793Daily closes, split-adjusted
Signals
50-day average1.928
200-day average1.924
Golden/death cross (60d)Golden, 0 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.242
Technical summary
Daily
Strongly bearish
3 bullish · 1 neutral · 12 bearish
Weekly
Strongly bearish
2 bullish · 1 neutral · 9 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
2.09
Bearish
EMA 10
2.00
Bearish
SMA 20
2.19
Bearish
EMA 20
2.05
Bearish
SMA 50
1.93
Bearish
EMA 50
1.96
Bearish
SMA 100
1.78
Bearish
EMA 100
1.92
Bearish
SMA 200
1.92
Bearish
EMA 200
2.12
Bearish
Oscillators (daily)
RSI (14)
42.56
Neutral
MACD (12, 26)
-0.02
Bearish
Momentum (12)
-19.61
Bearish
Stochastic %K (14)
2.44
Bullish
Williams %R (14)
-97.56
Bullish
CCI (20)
-134.4
Bullish
Pivot points (classic, last session)
S3
1.60
S2
1.66
S1
1.70
Pivot
1.76
R1
1.79
R2
1.85
R3
1.89
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in SEK. Educational only, not financial advice.
